Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics Previous close 6,353.00
Open 6,416.00
Day range 6,269.00 6,438.00
52-week range 5,974.00 10,700.00
Off day high −1.62%
Off 52-week high −40.80%
Volume 2.36M
Avg. volume (3M) 2.93M
Market cap 10.42T
EPS (TTM) 286.42
Forward P/E 26.85
P/E ratio (TTM) 22.11
Dividend yield 2.08% (132.00)
Beta (5Y) —
Shares outstanding 1.65B
Short interest —
Earnings date Oct 27, 2026
Analyst target —
Profit margin —
No recent coverage in the 4Search index.
From articles in the 4Search news index.
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO.
From Wikipedia , CC BY-SA 4.0
Earnings
Next report: Tue, Oct 27, 2026
Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).
Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).
Not eligible for Growth tech (U.S. technology stocks only).
Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).
A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.
Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use .